Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

SK801b

Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing SK801
Price: $215.00 Add to Cart
H&E (SK801bs*): $215.00 Add to Cart

Microarray Panel:Skin squamous cell carcinoma tissue microarray, containing 42 cases of skin squamous cell carcinoma, 14 skin basal cell carcinoma, 12 skin malignant melanoma, 1 each of skin sweat gland carcinoma and malignant trichoepithelioma, plus 10 adjacent normal skin tissue, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
B Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
C Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
D Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
E Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
F Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
G Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski  
H Bre Ski Ski Ski Ski Bre Bre Ski Ski Bre Marked point
Legend: Bre - Breast, Ski - Skin

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IV), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 73 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
A2 2 M 54 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A3 3 M 67 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A4 4 M 58 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A5 5 F 90 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A6 6 F 84 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A7 7 M 76 Skin Squamous cell carcinoma 1 II T3N0M0 Malignant
A8 8 M 73 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
A9 9 M 74 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
A10 10 M 72 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B1 11 M 64 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
B2 12 F 79 Skin Squamous cell carcinoma 2 II T2N0M0 Malignant
B3 13 F 56 Skin Squamous cell carcinoma 1 II T3N0M0 Malignant
B4 14 M 34 Skin Squamous cell carcinoma 1 II T3N0M0 Malignant
B5 15 F 86 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B6 16 M 61 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B7 17 M 55 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B8 18 F 88 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B9 19 M 65 Skin Squamous cell carcinoma 1 I T1N0M0 Malignant
B10 20 F 85 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
C1 21 F 80 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
C2 22 M 37 Skin Squamous cell carcinoma 1 II T3N0M0 Malignant
C3 23 M 56 Skin Squamous cell carcinoma (fibrous tissue and blood vessel) – II T2N0M0 Malignant
C4 24 M 66 Skin Squamous cell carcinoma 2 I T1N0M0 Malignant
C5 25 F 55 Skin Squamous cell carcinoma 2 II T3N0M0 Malignant
C6 26 M 66 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
C7 27 M 67 Skin Squamous cell carcinoma 1 II T3N0M0 Malignant
C8 28 F 64 Skin Squamous cell carcinoma (fibrofatty tissue) – II T2N0M0 Malignant
C9 29 M 60 Skin Squamous cell carcinoma 1 II T2N0M0 Malignant
C10 30 M 69 Skin Squamous cell carcinoma 2 II T3N0M0 Malignant
D1 31 M 47 Skin Squamous cell carcinoma (skin appendages) – II T2N0M0 Malignant
D2 32 M 64 Skin Squamous cell carcinoma 2 II T2N0M0 Malignant
D3 33 M 51 Skin Squamous cell carcinoma 2 II T3N0M0 Malignant
D4 34 M 58 Skin Squamous cell carcinoma 2 IV T3N0M1 Malignant
D5 35 M 67 Skin Squamous cell carcinoma 2 I T1N0M0 Malignant
D6 36 F 66 Skin Squamous cell carcinoma 2 I T1N0M0 Malignant
D7 37 M 68 Skin Squamous cell carcinoma 2 II T2N0M0 Malignant
D8 38 M 73 Skin Squamous cell carcinoma 2 II T2N0M0 Malignant
D9 39 M 71 Skin Squamous cell carcinoma 2 III T3N1M0 Malignant
D10 40 M 45 Skin Squamous cell carcinoma 3 II T2N0M0 Malignant
E1 41 M 72 Skin Squamous cell carcinoma 3 II T2N0M0 Malignant
E2 42 M 70 Skin Squamous cell carcinoma 3 II T3N0M0 Malignant
E3 43 M 64 Skin Basal cell carcinoma – II T2N0M0 Malignant
E4 44 M 62 Skin Basal cell carcinoma – I T1N0M0 Malignant
E5 45 M 57 Skin Basal cell carcinoma – II T2N0M0 Malignant
E6 46 M 48 Skin Basal cell carcinoma – II T2N0M0 Malignant
E7 47 F 74 Skin Basal cell carcinoma – II T2N0M0 Malignant
E8 48 M 74 Skin Basal cell carcinoma – II T2N0M0 Malignant
E9 49 F 64 Skin Basal cell carcinoma – II T2N0M0 Malignant
E10 50 M 48 Skin Basal cell carcinoma – I T1N0M0 Malignant
F1 51 M 60 Skin Basal cell carcinoma – II T2N0M0 Malignant
F2 52 M 54 Skin Basal cell carcinoma – II T2N0M0 Malignant
F3 53 M 38 Skin Basal cell carcinoma – I T1N0M0 Malignant
F4 54 F 63 Skin Basal cell carcinoma – II T2N0M0 Malignant
F5 55 F 62 Skin Basal cell carcinoma – I T1N0M0 Malignant
F6 56 F 70 Skin Basal cell carcinoma – I T1N0M0 Malignant
F7 57 M 53 Skin Malignant melanoma – II T4N0M0 Malignant
F8 58 M 55 Skin Malignant melanoma – II T4N0M0 Malignant
F9 59 M 76 Skin Malignant melanoma – II T4N0M0 Malignant
F10 60 M 78 Skin Malignant melanoma – I T1N0M0 Malignant
G1 61 M 65 Skin Malignant melanoma – II T2N0M0 Malignant
G2 62 F 41 Skin Malignant melanoma – II T4N0M0 Malignant
G3 63 M 74 Skin Malignant melanoma – II T4N0M0 Malignant
G4 64 M 42 Skin Malignant melanoma – IV T3N2M1 Malignant
G5 65 M 60 Skin Malignant melanoma – III T4N1M0 Malignant
G6 66 M 45 Skin Malignant melanoma – II T4N0M0 Malignant
G7 67 M 55 Skin Malignant melanoma – II T4N0M0 Malignant
G8 68 M 52 Skin Malignant melanoma – IV T4N1M1 Malignant
G9 69 M 64 Skin Sweat gland carcinoma with necrosis – II T2N0M0 Malignant
G10 70 F 65 Skin Malignant trichoepithelioma – II T3N0M0 Malignant
H1 71 F 53 Breast Cancer adjacent normal skin tissue – – – NAT
H2 72 M 73 Skin Cancer adjacent normal skin tissue – – – NAT
H3 73 M 75 Skin Cancer adjacent normal skin tissue – – – NAT
H4 74 F 42 Skin Cancer adjacent normal skin tissue – – – NAT
H5 75 F 50 Skin Cancer adjacent normal skin tissue – – – NAT
H6 76 F 49 Breast Cancer adjacent normal skin tissue – – – NAT
H7 77 F 49 Breast Cancer adjacent normal skin tissue – – – NAT
H8 78 M 56 Skin Cancer adjacent normal skin tissue – – – NAT
H9 79 F 37 Skin Cancer adjacent normal skin tissue – – – NAT
H10 80 F 62 Breast Cancer adjacent normal skin tissue – – – NAT
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal